|Description||SB 242084 hydrochloride is a selective and brain penetrant 5-HT2C receptor antagonist with over 100-fold selectivity versus a range of other 5-HT, dopamine and adrenergic receptors.|
|Brife Description||5-HT2C receptor antagonist|
|Related CAS||181632-25-7 (free base)|
|Synonyms||SB 242084 hydrochloride; SB242084 hydrochloride; SB-242084 hydrochloride; 6-chloro-2,3-dihydro-5-methyl-N-[6-[(2-methyl-3-pyridinyl)oxy]-3-pyridinyl]-1H-indole-1-carboxamide hydrochloride|
LY-53857 is a selective and potent 5-HT2 serotonin receptor antagonist. It was developed by Eli Lilly and Company.
BRL-15572 displays high affinity and selectivity for h5-HT1D receptors. BRL-15572 has 60-fold higher affinity for h5-HT1D than 5-HT1B receptors.
Lurasidone is an atypical antipsychotic, inhibits Dopamine D2, 5-HT2A, 5-HT7, 5-HT1A and noradrenaline α2C with IC50 of 1.68 nM, 2.03 nM, 0.495 nM, 6.75 nM and ...
Quipazine dimaleate is a slective 5-HT3 receptor agonist, and also displays antagonist activity at peripheral 5-HT3 receptors. Quipazine was shown to increase s...
U 92016A is an orally bioactive 5-HT1A full agonist with high intrinsic activity. Hypothermia, hypotension and 5-HT behavioral syndrome are caused by administra...
Paroxetine maleate is a highly potent and selective 5-HT uptake inhibitor that binds with high affinity to the serotonin transporter (Ki = 0.05 nM). Ki = 1.1, 3...
SB 228357 is a 5-HT2C/2B receptor antagonist (pKi = 7.0, 8.1 and 9.1 at 5-HT2A, 2B and 2C receptors, respectively) used in the treatment of irritable bowel synd...
Mirisetron maleate, an oxoquinoline derivative, has been found to be a 5-HT3 receptor antagonist that could probably be effective against anxiety disorders and ...